News Microbix Biosystems Inc.

Equities

Market Closed - Toronto S.E. Other stock markets 02:03:37 2024-06-06 pm EDT			5-day change	1st Jan Change
0.335 ^CAD	-1.47%		+4.69%	-14.10%

Jun. 04	Microbix Advancing Test-Ingredient Manufacturing Capabilities	MT
Jun. 04	Microbix Brief: Advancing Test-Ingredient Manufacturing Capabilities	MT

Microbix Advancing Test-Ingredient Manufacturing Capabilities	Jun. 04	MT
Microbix Brief: Advancing Test-Ingredient Manufacturing Capabilities	Jun. 04	MT
Microbix Advances Test-Ingredient Manufacturing Capabilities	Jun. 04	GL
Microbix Biosystems Up More Than 10% As Q2 Profit Grows On Higher Revenues; Says Stage Set For Record FY	May. 15	MT
Transcript : Microbix Biosystems Inc., Q2 2024 Earnings Call, May 15, 2024	May. 15
Microbix Brief: Q2 Revenues of $5.6 million and Net Income of $0.4 million	May. 15	MT
Microbix Reports Strong Results for Q2 Fiscal 2024	May. 15	GL
Microbix Biosystems Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 15	CI
Microbix Schedules Release of Results for Q2 Fiscal 2024	May. 08	GL
Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology	Apr. 25	MT
Microbix Collaborator Introduces New Lab Accreditation Program	Apr. 25	CI
Microbix Collaborator Introduces New Lab Accreditation Program	Apr. 25	GL
Microbix Presenting at the 2024 Bloom Burton Conference	Apr. 11	GL
Microbix Announces Annual and Special Meeting Voting Results	Apr. 01	GL
Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call	Mar. 27
Microbix Says Clot-Buster Drug Project Advancing	Mar. 14	MT
Microbix Brief: Says Clot-Buster Drug Project Advancing	Mar. 14	MT
Microbix’s Clot-Buster Drug Project Advances	Mar. 14	GL
Microbix?S Clot-Buster Drug Project Advances	Mar. 14	CI
Microbix Unveiling Test Controls for Head and Neck Cancer	Mar. 11	MT

No results for this search